LimFlow, Now Part of Stryker

medical devices

About

LimFlow is a medical technology company focused on innovative treatments for Chronic Limb-Threatening Ischemia (CLTI), a severe form of peripheral artery disease. The company aims to provide effective solutions for patients at risk of amputation due to critically reduced blood flow to the limbs. LimFlow has developed a minimally invasive procedure that reroutes blood flow through the veins below the knee, effectively turning a vein into an artery to restore oxygen and nutrients to the affected limb. The core product, the LimFlow System, includes proprietary technologies such as ultrasound catheters and specialized stents. This FDA-approved system is designed for patients with unreconstructible arteries, offering a permanent bypass solution. LimFlow also provides clinical education and support to healthcare professionals, enhancing therapy adoption and improving patient outcomes. As part of the Inari Medical family and integrated within Stryker, LimFlow benefits from extensive resources to further its mission of improving outcomes for patients with severe vascular disease.

Technologies

CSC Corporate Domains Mailchimp Mandrill Outlook Microsoft Office 365 Remote AI

Keywords

critical limb ischemia wound healing amputation free endovascular perfusion venous arterialization desert foot diabetic foot rutherford 5 rutherford 6 cli fighter medical equipment manufacturing peripheral artery disease treatment arterial bypass technology vascular intervention innovation arterial bypass system minimally-invasive procedure vascular surgery alternative vascular disease treatment chronic limb ischemia deep vein arterialization system vascular system medical equipment and supplies manufacturing blood flow bypass vascular health vascular intervention system medical device b2b vascular bypass system peripheral artery disease

Location

6001 Oak Cyn, Irvine, California, United States, 92618

Related Companies

Companies in the same industry